Everolimus Based Immunosuppression in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 24 Month Results from a Randomized Controlled Trial.

被引：0
|
作者：
Saliba, F. [1 ]
Brown, R. S., Jr. [1 ]
Metselaar, H. [1 ]
Beckebaum, S. [1 ]
Duvoux, C. [1 ]
Navasa, M. [1 ]
Dong, G. [2 ]
Lopez, P. [3 ]
Nevens, F. [1 ]
机构：
[1] H2304 Study Grp, Villejuif, France
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S100 / S101
页数：2
相关论文
共 50 条
  • [41] EVEROLIMUS PLUS REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS ACHIEVES COMPARABLE OVERALL EFFICACY WITH FEWER BIOPSY-PROVEN ACUTE REJECTIONS VERSUS STANDARD TACROLIMUS: 24-MONTH RESULTS OF A RANDOMIZED TRIAL
    Fung, J.
    Fischer, L.
    Kaiser, G.
    Jonas, S.
    Heise, M.
    Schemmer, P.
    Pascher, A.
    Schlitt, H.
    Paulus, E.
    Mertens, M.
    Nevens, F.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 4 - 4
  • [42] Denosumab Prevents Bone Mineral Density Loss in De Novo Kidney Transplant Recipients: Results from a Randomized Controlled Trial
    Bonani, M.
    Frey, D.
    Brockmann, J.
    Fehr, T.
    Muller, T.
    Graf, N.
    Wuthrich, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 323 - 323
  • [43] Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression
    McKenna, G. J.
    Trotter, J. F.
    Klintmalm, E.
    Onaca, N.
    Ruiz, R.
    Jennings, L. W.
    Neri, M.
    O'Leary, J. G.
    Davis, G. L.
    Levy, M. F.
    Goldstein, R. M.
    Klintmalm, G. B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (11) : 2379 - 2387
  • [44] Limiting Hepatitis C Virus (HCV) Progression in Liver Transplant Recipients Using Sirolimus Based Immunosuppression
    McKenna, Greg J.
    Trotter, James
    Klintmalm, Erik
    Chinnakotla, Srinath
    Randall, Henry
    Onaca, Nicholas
    Ruiz, Richard
    Levy, Marlon F.
    Goldstein, Robert M.
    Klintmalm, Goran B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 76 - 77
  • [45] Concentration-Controlled Everolimus with Reduced Cyclosporine Concentration in De Novo Renal Transplant Recipients: Efficacy Results at 24 Months.
    Tedesco-Silva, H.
    Kim, Y. S.
    Johnston, T.
    Walker, R.
    Zibari, G. B.
    Cornu-Artis, C.
    Wang, Z.
    Cibrik, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 46 - 46
  • [46] Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial
    De Simone, P.
    Detry, O.
    Kintmalm, G.
    Goss, J.
    McCormick, P.
    Rossi, M.
    Moya, A.
    Lopez, P.
    Junge, G.
    Dong, G.
    Joseph, D.
    Duvoux, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 169 - 170
  • [47] Protein Kinase C Inhibitor Sotrastaurin in De Novo Liver Transplant Recipients: A Randomized Phase II Trial
    Pascher, A.
    De, P. Simone
    Pratschke, J.
    Salame, E.
    Pirenne, J.
    Isoneimi, H.
    Bijarnia, M.
    Krishnan, I.
    Klupp, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (05) : 1283 - 1292
  • [48] 24-Month Safety and Efficacy of Concentration Controlled Everolimus with Reduced Cyclosporine Versus Mycophenolate Mofetil in 721 De Novo Heart Transplant Recipients: Results from the A2310 Study
    Epailly, E.
    Eisen, H.
    Pauly, D.
    Hirt, S.
    Lehmkuhl, H.
    Andreassen, A.
    Rinaldi, M.
    Yonan, N.
    Potena, L.
    Zuckermann, A.
    Dong, G.
    Panis, C.
    Lopez, P.
    Kobashigawa, J.
    TRANSPLANTATION, 2012, 94 (10) : 127 - 127
  • [49] mTOR Inhibition with Everolimus in De Novo Living Donor Liver Transplantation-24-Months Results from the H2307 Pivotal Trial.
    Jeng, L.
    Lee, S.
    Soin, A.
    Uemoto, S.
    Maluf, D.
    Emond, J.
    Meier, M.
    Kochuparampil, J.
    Sips, C.
    Kaneko, S.
    Levy, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 269 - 269
  • [50] Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
    Chapman, William C.
    Brown, Robert S.
    Chavin, Kenneth D.
    Sudan, Debra
    Koneru, Baburao
    Junge, Guido
    Dong, Gaohong
    Patel, Dharmesh
    Teperman, Lewis
    Fung, John J.
    TRANSPLANTATION, 2017, 101 (02) : 341 - 349
12345